Eledon Pharmaceuticals, Inc. Allowance for Loan and Lease Losses, Adjustments, Other
Eledon Pharmaceuticals, Inc. (ELDN) reported Allowance for Loan and Lease Losses, Adjustments, Other of $49.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-03.
Discontinued › Notes
us-gaap:AllowanceForLoanAndLeaseLossesAdjustmentsNet · last filed 2017-03-03
- Eledon Pharmaceuticals, Inc. allowance for loan and lease losses, adjustments, other for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- Eledon Pharmaceuticals, Inc. allowance for loan and lease losses, adjustments, other for the quarter ending 2015-09-30 was $0.00, a 100.00% decline year-over-year.
- Eledon Pharmaceuticals, Inc. allowance for loan and lease losses, adjustments, other for the quarter ending 2015-06-30 was $15.00K, a 55.88% decline year-over-year.
- Eledon Pharmaceuticals, Inc. allowance for loan and lease losses, adjustments, other for the quarter ending 2015-03-31 was $34.00K, a 24.44% decline year-over-year.
- Eledon Pharmaceuticals, Inc. allowance for loan and lease losses, adjustments, other for fiscal 2015 was $49.00K, a 68.99% decline from fiscal 2014.
- Eledon Pharmaceuticals, Inc. allowance for loan and lease losses, adjustments, other for fiscal 2014 was $158.00K.
| Period end | Allowance for Loan and Lease Losses, Adjustments, Other 3 month | Allowance for Loan and Lease Losses, Adjustments, Other 6 month | Allowance for Loan and Lease Losses, Adjustments, Other 9 month | Allowance for Loan and Lease Losses, Adjustments, Other 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $0.00 derived: sum of 2 quarters · filed 2017-03-03 | $15.00K derived: sum of 3 quarters · filed 2017-03-03 | $49.00K 10-K · filed 2017-03-03 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $15.00K derived: sum of 2 quarters · filed 2016-11-03 | $49.00K 10-Q · filed 2016-11-03 | $94.00K derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $49.00K 10-Q · filed 2016-08-04 | $94.00K derived: sum of 3 quarters · filed 2017-03-03 | $128.00K derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-03-31 | $34.00K 10-Q · filed 2016-05-10 | $79.00K derived: sum of 2 quarters · filed 2017-03-03 | $113.00K derived: sum of 3 quarters · filed 2017-03-03 | $147.00K derived: sum of 4 quarters · filed 2017-03-03 |
| 2014-12-31 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $79.00K derived: sum of 2 quarters · filed 2017-03-03 | $113.00K derived: sum of 3 quarters · filed 2017-03-03 | $158.00K 10-K · filed 2017-03-03 |
| 2014-09-30 | $34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $68.00K derived: sum of 2 quarters · filed 2015-11-10 | $113.00K 10-Q · filed 2015-11-10 | |
| 2014-06-30 | $34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $79.00K 10-Q · filed 2015-08-12 | ||
| 2014-03-31 | $45.00K 10-Q · filed 2015-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |